CClinicalTrials.gg
Not yet recruitingNCT07608211DSRPDUpdated Jun 1, 2026

Development of a Sanitizing Tablet for Removable Partial Dentures

An interventional study of Experimental Effervescent Tablet (NAC/Melaleuca) and Commercial Cleansing Tablet (NitrAdine) in Denture Stomatitis, sponsored by University of Sao Paulo. Not yet recruiting at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a new experimental effervescent tablet works to clean removable partial dentures. It will test if the tablet lowers bacteria and fungi on denture surfaces. The main questions it aims to answer are: Does the experimental tablet lower the number of microbes on different denture materials? How happy are participants with the taste, odor, and cleanliness of the tablet? Researchers will compare the experimental tablet to a known commercial cleanser and to a neutral water solution to see which one works best. Total participation will last 70 days. First, researchers will place small material discs on the side of the participant's current denture to collect natural plaque. Participants will wear their dentures 24 hours a day and brush them with soap and water after meals. Participants will then cycle through three separate 14-day testing phases. In each phase, participants will soak their dentures daily for 15 minutes in one of the assigned solutions. Participants will also have a 7-day break between each phase where they return to their basic regular cleaning routine. At the end of each testing phase, researchers will remove the small discs to count the microbes in a laboratory. Participants will also answer a short survey about their satisfaction with each product.

02

Conditions studied

  • Denture Stomatitis

Browse trials for

03

In context

Stomatitis, Denture

23 studies on the registry are indexed under Stomatitis, Denture; 1 is open to participants now.

This study's planned enrollment of 15 is below the median of 30 across 19 interventional studies indexed under Stomatitis, Denture.

Browse Stomatitis, Denture studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants aged 18 years or older.
  • Users of maxillary and/or mandibular removable partial dentures (RPD) made of acrylic resin.
  • Good systemic and oral health status, with enough healthy remaining teeth to support the RPD.
  • Agreement to follow the requested oral hygiene and denture cleaning protocols.
  • Ability to understand and sign the Informed Consent Form.

Exclusion criteria

Exclusion Criteria:

  • Use of systemic antibiotics, antifungals, or anti-inflammatory drugs within the last 3 months.
  • History of allergic reactions to N-acetylcysteine (NAC), Melaleuca alternifolia (tea tree) oil, or components of the commercial positive control (NitrAdine).
  • Severe periodontal disease or extensive untreated caries in the remaining teeth.
  • Severe systemic diseases, immunodeficiency, or conditions that compromise manual dexterity to perform denture brushing.
  • Pregnant or lactating women.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Experimental Tablet (NAC/Melaleuca)

    Participants will brush their dentures daily for 2 minutes using water and neutral soap after main meals. Once a day, they will also soak their dentures for 15 minutes in an effervescent solution formulated with N-acetylcysteine (NAC) and Melaleuca oil.

    Device: Experimental Effervescent Tablet (NAC/Melaleuca)

  • Active comparator
    Active Control (NitrAdine)

    Participants will brush their dentures daily for 2 minutes using water and neutral soap after main meals. Once a day, they will also soak their dentures for 15 minutes in a solution using the commercial cleansing tablet NitrAdine.

    Device: Commercial Cleansing Tablet (NitrAdine)

  • Placebo comparator
    Placebo Control (PBS)

    Participants will brush their dentures daily for 2 minutes using water and neutral soap after main meals. Once a day, they will also soak their dentures for 15 minutes in a neutral Phosphate-Buffered Saline (PBS) solution.

    Other: Phosphate-Buffered Saline (PBS)

Interventions

  • DeviceExperimental Effervescent Tablet (NAC/Melaleuca)

    An experimental effervescent tablet formulated with N-acetylcysteine (NAC) and Melaleuca alternifolia (Tea Tree) essential oil, designed for the daily chemical cleaning of removable partial dentures via a 15-minute immersion.

  • DeviceCommercial Cleansing Tablet (NitrAdine)

    A commercially available disinfecting tablet used as a positive control for the chemical cleaning of removable partial dentures via a daily 15-minute immersion.

  • OtherPhosphate-Buffered Saline (PBS)

    A neutral saline solution used as a negative control/placebo for the daily 15-minute denture immersion, serving to establish a baseline for mechanical cleaning alone.

06

What researchers measure

Primary outcomes

  1. Microbial Load (Colony Forming Units)

    The microbial load of Candida spp., Streptococcus mutans, Staphylococcus spp., Gram-negative species, and total aerobes collected from the biofilm on the denture specimens will be evaluated using CFU counts per milliliter (CFU/mL).

    Time frame: Baseline (Day 14), Day 28, Day 49, and Day 70

Secondary outcomes

  1. Biofilm Cell Viability via Flow Cytometry

    The percentage of live, damaged, and dead microbial cells within the denture biofilm will be quantified using flow cytometry with viability staining (e.g., SYTO 9 and propidium iodide) to evaluate the antimicrobial efficacy of the cleaning methods.

    Time frame: Baseline (Day 14), Day 28, Day 49, and Day 70

  2. Biofilm Gene Expression

    The relative expression levels of specific virulence and biofilm-associated genes of target microorganisms (e.g., Candida albicans) will be quantified using Real-Time Quantitative Reverse Transcription PCR (RT-qPCR) to understand the molecular impact of the interventions.

    Time frame: Baseline (Day 14), Day 28, Day 49, and Day 70

  3. Participant Satisfaction and Perception of Cleanliness

    Participant perception regarding denture cleanliness, comfort, taste, and overall satisfaction with each cleaning protocol will be assessed using a structured Likert scale questionnaire. Total scores range from 1 to 5, where 1 indicates "Highly Unsatisfied" (worst possible outcome) and 5 indicates "Highly Satisfied" (best possible outcome). Higher scores represent a better outcome (higher satisfaction and better perception of cleanliness).

    Time frame: Day 28, Day 49, and Day 70

07

Study locations

1 site
  • School of Dentistry of Ribeirão Preto
    Ribeirão Preto, São Paulo 14051260, Brazil
08

References and documents

Publications

  • Moraes LGDS, Oliveira VC, Macedo AP, Freiria de Oliveira CA, Watanabe E, Pagnano VO. Enhancing Removable Partial Denture Hygiene: Investigating Mucolytic Agents and Biocides for Disrupting Biofilms and Improving Antimicrobial Efficacy. Int J Prosthodont. 2025 Sep 25;38(5):559-569. doi: 10.11607/ijp.9133. PubMed 39331828 ↗
  • Correa PGL, Cruz-Araujo SR, Freiria de Oliveira CA, Silva RRD, Oliveira VC, Pagnano VO, Silva-Lovato CH, Galo R, Stirke A, Melo WCMA, Macedo AP. Evaluation of Colonization by Candida albicans and Biofilm Formation on 3D-Printed Denture Base Resins. Materials (Basel). 2025 Nov 4;18(21):5018. doi: 10.3390/ma18215018. PubMed 41227976 ↗
  • Freiria de Oliveira CA, Macedo AP, Oliveira VC, de Moraes LGS, Tonin BSH, Galo R, Pagnano VO. Impact of Peracetic Acid and Cetylpyridinium Chloride Disinfection on Removable Partial Denture Materials. Int J Prosthodont. 2025 Sep 16;0(0):1-21. doi: 10.11607/ijp.9470. Online ahead of print. PubMed 40957068 ↗
  • Freiria de Oliveira CA, Moraes LGDS, Vilela Teixeira AB, Pagnano VO. Antimicrobial activity of cleansers on the cobalt-chromium surface of removable partial denture: a systematic review. Biofouling. 2023 Oct-Nov;39(9-10):916-927. doi: 10.1080/08927014.2023.2290120. Epub 2023 Dec 4. PubMed 38047547 ↗

Individual participant data

Plan to share: No — To do not interrupt the patent process

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07608211
Lead sponsor
University of Sao Paulo
Responsible party
Carolina Alves Freiria de Oliveira (PhD student, University of Sao Paulo) — Principal investigator
First posted
May 27, 2026
Start date
Jun 8, 2026 (estimated)
Primary completion
Sep 14, 2026 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Jun 1, 2026

Study contacts

Carolina Alves Freiria de Oliveira, PhD student
Contact
carolina.alves.oliveira@usp.br
+5535992436266

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion